Share-based Payment Arrangement, Expense of Neurogene Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Neurogene Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Neurogene Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $3,365,000, a 36% increase year-over-year.
  • Neurogene Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $13,308,000, a 115% increase year-over-year.
  • Neurogene Inc. annual Share-based Payment Arrangement, Expense for 2024 was $8,320,000, a 487% increase from 2023.
  • Neurogene Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1,418,000, a 13% increase from 2022.
  • Neurogene Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1,252,000, a 89% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Neurogene Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $13,308,000 $3,365,000 +$891,000 +36% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $12,417,000 $3,408,000 +$1,094,000 +47% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $11,323,000 $4,048,000 +$3,003,000 +287% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $8,320,000 $2,487,000 +$2,132,000 +601% 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q3 2024 $6,188,000 $2,474,000 +$2,088,000 +541% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $4,100,000 $2,314,000 +$1,930,000 +503% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $2,170,000 $1,045,000 +$752,000 +257% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $1,418,000 $355,000 +$5,892,000 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $4,474,000 $386,000 -$1,645,000 -81% 01 Jul 2023 30 Sep 2023 10-Q 18 Nov 2024 2024 Q3
Q2 2023 $2,829,000 $384,000 -$1,928,000 -83% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $901,000 $293,000 -$2,153,000 -88% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $1,252,000 $5,537,000 -$8,546,000 -284% 01 Oct 2022 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 $9,798,000 $2,031,000 -$1,179,000 -37% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $10,977,000 $2,312,000 -$606,000 -21% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $11,583,000 $2,446,000 +$26,000 +1.1% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q4 2021 $11,557,000 $3,009,000 +$780,000 +35% 01 Oct 2021 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q3 2021 $10,777,000 $3,210,000 +$1,522,000 +90% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $9,255,000 $2,918,000 +$1,896,000 +186% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $7,359,000 $2,420,000 +$1,737,000 +254% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $5,622,000 $2,229,000 +$1,585,000 +246% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $4,037,000 $1,688,000 -$3,463,000 -67% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $7,500,000 $1,022,000 +$234,000 +30% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $7,266,000 $683,000 -$417,000 -38% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q4 2019 $7,683,000 $644,000 +$244,000 +61% 01 Oct 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $7,439,000 $5,151,000 +$3,651,000 +243% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $3,788,000 $788,000 -$712,000 -47% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $4,500,000 $1,100,000 -$200,000 -15% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $4,700,000 $400,000 -$500,000 -56% 01 Oct 2018 31 Dec 2018 10-K 07 Mar 2019 2018 FY
Q3 2018 $5,200,000 $1,500,000 +$300,000 +25% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
Q2 2018 $4,900,000 $1,500,000 +$400,000 +36% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $4,500,000 $1,300,000 +$700,000 +117% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q4 2017 $3,800,000 $900,000 +$333,000 +59% 01 Oct 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 $3,467,000 $1,200,000 +$700,000 +140% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $2,767,000 $1,100,000 +$600,000 +120% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $2,167,000 $600,000 +$167,000 +39% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q4 2016 $2,000,000 $567,000 +$212,000 +60% 01 Oct 2016 31 Dec 2016 10-K 07 Mar 2019 2018 FY
Q3 2016 $1,788,000 $500,000 +$76,000 +18% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $1,712,000 $500,000 +$45,000 +9.9% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $1,667,000 $433,000 +$167,000 +63% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $1,500,000 $355,000 +$87,000 +32% 01 Oct 2015 31 Dec 2015 10-K 12 Mar 2018 2017 FY
Q3 2015 $1,413,000 $424,000 +$191,000 +82% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $1,222,000 $455,000 +$240,000 +112% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q1 2015 $982,000 $266,000 +$128,000 +93% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q4 2014 $854,000 $268,000 01 Oct 2014 31 Dec 2014 10-K 09 Mar 2017 2016 FY
Q3 2014 $233,000 01 Jul 2014 30 Sep 2014 10-Q 10 Nov 2015 2015 Q3
Q2 2014 $215,000 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 $138,000 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015 2015 Q1

Neurogene Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $8,320,000 +$6,902,000 +487% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2023 $1,418,000 +$166,000 +13% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 $1,252,000 -$10,305,000 -89% 01 Jan 2022 31 Dec 2022 10-K 18 Mar 2024 2023 FY
2021 $11,557,000 +$5,935,000 +106% 01 Jan 2021 31 Dec 2021 10-K 20 Mar 2023 2022 FY
2020 $5,622,000 -$2,061,000 -27% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
2019 $7,683,000 +$2,983,000 +63% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 $4,700,000 +$900,000 +24% 01 Jan 2018 31 Dec 2018 10-K 07 Mar 2019 2018 FY
2017 $3,800,000 +$1,800,000 +90% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
2016 $2,000,000 +$500,000 +33% 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019 2018 FY
2015 $1,500,000 +$646,000 +76% 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018 2017 FY
2014 $854,000 +$505,000 +145% 01 Jan 2014 31 Dec 2014 10-K 09 Mar 2017 2016 FY
2013 $349,000 -$2,322 -0.66% 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
2012 $351,322 +$233,079 +197% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
2011 $118,243 +$8,987 +8.2% 01 Jan 2011 31 Dec 2011 10-Q 13 May 2014 2014 Q1
2010 $109,256 01 Jan 2010 31 Dec 2010 10-Q 13 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.